Future Trials by Concept Medical

SFA and BTK Clinical Trials.

[Medical Device News Magazine @MedDeviceNews1]

@conceptmedicals Medical Reports Index Patient Enrollment in World’s 1st RCT with Sirolimus Coated Balloon https://t.co/sE9cxACgae

[PRN Europe Health @PRNEHealth]

Concept Medical announces index patient enrolment in world's first Randomized Controlled Trial with Sirolimus Coated Balloon for the treatment of Superficial Femoral Artery (SFA) in Peripheral Artery Disease https://t.co/qnMB0ni9a9

[Pharma & Life Science News @pharminews]

Concept Medical announces index patient enrolment in world's first Randomized Controlled Trial with Sirolimus Coated Balloon for the treatment of Superficial Femoral Artery (SFA) in Peripheral Artery Disease
https://t.co/v4fw0M4XIt
#news #pharma #pharmiweb

[MedPub Cardiology @MedPubCardio]

Concept Medical announces index patient enrolment in world's first Randomized Controlled Trial with Sirolimus Coated Balloon for the treatment of Superficial Femoral Artery (SFA) in Peripheral Artery Disease
#CardioTwitter #MedTwitter #MedEd
https://t.co/NGcRvtQQWj

[CardiacVascularNews @CardiacVascNews]

Concept Medical announces index patient enrolment in world's first Randomized Controlled Trial with Sirolimus Coated Balloon for the treatment of Superficial Femoral Artery (SFA) in Peripheral Artery Disease https://t.co/xRTWYSnAJY

[Future Trials by Concept Medical @future_trials]

https://t.co/l3iiNvQ4Kg

[Future Trials by Concept Medical @future_trials]

On 11 September 2020, Enrolment of the first patient in the FUTURE SFA TRIAL by Dr. #EdwardChoke and his team at Sengkang General Hospital Singapore.
Read More: https://t.co/w9giTRzoqD
#FutureSFA
#Clinicaltrial
#MagicTouchPTA
#DrugCoatedBalloon
@conceptmedicals

[Future Trials by Concept Medical @future_trials]

Thank you @TCTMD for featuring @future_trials for enrolment of the first patient in the FUTURE BTK Clinical Trial.
#FutureBTK
#Clinicaltrials
@crfheart @TCTMD
https://t.co/qj9qxaqVml

[Future Trials by Concept Medical @future_trials]

Thank you @PCRonline PCRonline for featuring @future_trials for enrolment of the first patient in the FUTURE BTK Clinical Trial.
#Futurebtk
#clinicalstrial
#clinicaltrials
@EuroInterventio
https://t.co/kQwMvXvXVU

[Future Trials by Concept Medical @future_trials]

Thank you @VascularNews for featuring @future_trials for enrolment of the first patient in the FUTURE BTK #ClinicalTrial.
#Futurebtk
#clinicalstrials
https://t.co/lVjzU9uFHC

[Pharma & Life Science News @pharminews]

Enrolment initiated in World's First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease
https://t.co/KFpOEGRXt1
#news #pharma #pharmiweb

[Future Trials by Concept Medical @future_trials]

Last August, @conceptmedicals announced it was granted FDA Breakthrough Device Designation for the MagicTouch PTA by the FDA for the treatment of below-the-knee disease.
Read more: https://t.co/hH6jqFPV4k

[Future Trials by Concept Medical @future_trials]

Enrolment of the first patient in #FUTUREBTK CLINICAL TRIAL, World’s First RCT with Sirolimus Coated Balloon for the Treatment of Peripheral Artery Disease in Below-the-Knee (BTK) by Dr Edward Choke and his team at Sengkang General Hospital Singapore.